H.R. 2821 · 119TH CONGRESSSenate · Jul 21, 2026
FDA Modernization Act 3.0
Take Action
Introduced
HousePassed
Senate
Resolving Differences
President
Became Law
Description
FDA Modernization Act 3.0
Step 3 of 6 · Senate
FDA Modernization Act 3.0
Mr. Guthrie moved to suspend the rules and pass the bill.
Jul 20, 2026
Considered under suspension of the rules. (consideration: CR H4639-4640)
Jul 20, 2026
DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
Jul 20, 2026
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
Jul 20, 2026
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
Jul 20, 2026
Motion to reconsider laid on the table Agreed to without objection.
Jul 20, 2026
FDA Modernization Act 3.0